Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE

DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Standard Dose
20MG;20MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE is listed in Drugs@FDA under application 212472 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 20MG;20MG Sponsor ACTAVIS LABS FL INC Submission history Latest submission status date: 2022-03-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE is listed in Drugs@FDA under application 212472 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 20MG;20MG Sponsor ACTAVIS LABS FL INC Submission history Latest submission status date: 2022-03-01 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline